CLINICAL_TRIALS
withdrawal
· 2016-05-26
Clinical Trial Update: Tiotropium for Smoking Asthmatics Study [Phase 4]
Summary
A Phase 4 trial evaluating tiotropium in smokers with asthma has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Alberta | Conditions: Asthma | Phase 4 | Status: WITHDRAWN